Loading insider details...
Beta
Latest Form 4 (Jun 23, 2026): Exercise/Conversion of 2,816 AGIO shares.
Every alert includes an AI-written analysis of the filing, plus news and market context.
| Filed | Company | Transaction | Shares | Value |
|---|---|---|---|---|
| Jun 23, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,816 | n/a |
| Jun 16, 2026 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 1,976 | n/a |
| Mar 27, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Exercise/Conversion | 23,509 | n/a |
| Mar 10, 2026 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 263,005 | n/a |
| Jun 23, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 2,120 | n/a |
| Jun 17, 2025 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 1,977 | n/a |
| Mar 26, 2025 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 319,976 | n/a |
| Sep 25, 2024 | ACADIA PHARMACEUTICALS INC (ACAD) | Grant/Award | 353,261 | n/a |
| Jun 24, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Grant/Award | 2,120 | n/a |
| Jun 17, 2024 | AGIOS PHARMACEUTICALS, INC. (AGIO) | Exercise/Conversion | 1,976 | n/a |